세계의 수술용 스펀지 시장 : 유형별, 소재별, 형상별, 무균성별, 용도별, 최종 사용자별, 지역별 예측(-2029년)

The global surgical sponges market is valued at an estimated 0.81 billion in 2024 and is projected to reach USD 1.19 billion by 2029, at a CAGR of 7.9% during the forecast period. The rise in trauma cases and accidents, as well as the development of the healthcare infrastructure, are the primary drivers of the surgical sponges market's growth. Sterile surgical sponges and other useful surgical supplies are becoming more and more necessary as the frequency of procedures linked to trauma and accidents rises. Therefore, if trauma and accidents become more widespread, there will likely be a greater need for surgical sponges.

"The x-ray detectable sponges segment is projected to witness highest growth rate in the surgical sponges market, by type, during the forecast period"

Based on type, the surgical sponges market is segmented into x-ray detectable sponges, cotton gauze sponges, laparotomy sponges, nonwoven sponges, and other surgical sponges. The ability of x-ray detectable sponges to significantly enhance patient safety by reducing the risk of retained surgical items by identifying leftover surgical items such as surgical sponges during surgical procedures, contributes to their extensive usage and market demand during the forecast period.

"The cotton segment is projected to witness the highest growth rate in the surgical sponges market, by material, during the forecast period."

Based on material, the surgical sponges market is segmented into cotton, rayon, PVA, and other materials. Cotton is cost-effective, it also have high absorbency, and it is easily available material in most of the regions. Which is making cotton a best choice for hospitals and ambulatory surgical centers, especially in high-volume settings. These factors are contributing to growth of this segment.

"The square & rectangle segment is projected to witness the highest growth rate in the surgical sponges market, in 2023, by shape"

Based on shape, the surgical sponges market is segmented into round & cylindrical, square & rectangle, and other shapes. The square and rectangular shapes make surgical sponges suitable for a range of surgical applications where effective blood and other fluid absorption and coverage are required. Which is contributing to their extensive adoption and market demand during the forecast period.

"The hospitals & ambulatory surgery centers segment is projected to witness the highest growth rate in the surgical sponges market in 2023, by end user".

Based on end users, the surgical sponges market is segmented hospitals & ambulatory surgery centers, and specialty clinics. The expansion of healthcare infrastructure, particularly in emerging markets, has led to an increase in number of hospitals and ASCs, driving demand for surgical sponges among these end users during the forecasted period.

"The Asia Pacific region is projected to witness highest growth rate in the surgical sponges market during the forecast period"

The global surgical sponges market is segmented into six regions - North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the surgical sponges market is expected to grow at the fastest rate in the Asia Pacific region. Over the projected period, the Asia Pacific market is expected to develop at the greatest rate due to factors such government initiatives to raise awareness about illness management and the growing number of hospitals and clinics in China and India.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America - 35%, Europe - 24%, Asia Pacific - 26%, Latin America - 12%, Middle East & Africa - 2%, and the GCC Countries - 1%

Lists of Companies Profiled in the Report:

Johnson & Johnson Services, Inc. (US), Medline Industries, LP (US), Cardinal Health (US), Integra LifeSciences Corporation (US), Dynarex corporation (US), 3M (US), Medicom (Canada), McKesson Corporation (US), Dukal, LLC (US), DeRoyal Industries, Inc. (US), Owens & Minor Inc. (US), AdvaCare Pharma (US), First aid bandage company (US), AllCare (US), Narang Medical Limited (India), Molnlycke Health Care AB (Sweden), Aegis Lifesciences (India), SUNDARAM SURGICAL (India), Omni International Corp (US), and Aspen Surgical Products, Inc.(US).

Research Coverage:

In this report, the surgical sponges market has been categorized based on material (cotton, rayon, PVA, and other materials), end user (hospitals & ambulatory surgery centers, and specialty clinics), sterility (sterile surgical sponge, and non-sterile surgical sponge), type (x-ray detectable sponges, cotton gauze sponges, laparotomy sponges, nonwoven sponges, and other surgical sponges), application (general surgery, neurosurgery, laparotomy, dental surgery, ENT surgery, and other applications), shape (round & cylindrical, square & rectangle, and other shapes), and region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries).

Comprehensive information regarding the main drivers, barriers, opportunities, and trends influencing the surgical sponges market's expansion is included in detail in this study. An exhaustive study of the key players in the surgical sponges market has been done to provide insights into their business profile, products offered, noteworthy strategies, acquisitions and expansions, and other recent activities pertaining to the market. This study examines the competitive landscape of emerging surgical sponge startups.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall surgical sponges market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, trends, opportunities, and restaints.

The report provides insights on the following pointers:

• Analysis of key drivers: (Rising number of surgical procedures performed, increasing cases of trauma and accidents, growing gearitric population and increasing prevalence of chronic diseases, and growing healthcare infrastructure), restraints (Risk of retained surgical items (RSIs)), opportunities (Increased adoption of outpatient surgeries, and growth opportunities in emerging economies), and trends (Technological advancements in surgical sponges, and developmentand adoption of biodegradable surgical sponges) influencing the growth of the in surgical sponges market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the surgical sponges market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the surgical sponges market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Johnson & Johnson Services, Inc. (US), Cardinal Health (US), and McKesson Corporation (US) are among others, in the surgical sponges market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 STUDY ASSUMPTIONS
  • 2.5.1 GROWTH RATE ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SURGICAL SPONGES MARKET OVERVIEW
• 4.2 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY TYPE AND COUNTRY (2023)
• 4.3 SURGICAL SPONGES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 SURGICAL SPONGES MARKET: REGIONAL MIX (2024-2029)
• 4.5 SURGICAL SPONGES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising number of surgical procedures performed
    • 5.2.1.2 Increasing trauma and accident cases
    • 5.2.1.3 Growing geriatric population and increasing prevalence of chronic diseases
    • 5.2.1.4 Healthcare infrastructural development and expansion
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Risk of retained surgical items
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth opportunities in emerging economies
    • 5.2.3.2 Increased adoption of outpatient surgeries
  • 5.2.4 TRENDS
    • 5.2.4.1 Development and adoption of biodegradable surgical sponges
    • 5.2.4.2 Technological advancements in surgical sponges
• 5.3 PRICING ANALYSIS
  • 5.3.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
  • 5.3.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
  • 5.6.1 SURGICAL SPONGES MARKET: ROLE IN ECOSYSTEM
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF SUPPLIERS
  • 5.7.4 BARGAINING POWER OF BUYERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.8.2 BUYING CRITERIA
• 5.9 REGULATORY LANDSCAPE
  • 5.9.1 NORTH AMERICA
    • 5.9.1.1 US
    • 5.9.1.2 Canada
  • 5.9.2 EUROPE
  • 5.9.3 ASIA PACIFIC
    • 5.9.3.1 Japan
    • 5.9.3.2 China
    • 5.9.3.3 India
  • 5.9.4 LATIN AMERICA
    • 5.9.4.1 Brazil
    • 5.9.4.2 Mexico
  • 5.9.5 MIDDLE EAST
  • 5.9.6 AFRICA
  • 5.9.7 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR SURGICAL SPONGES
  • 5.10.2 EXPORT DATA FOR SURGICAL SPONGES
• 5.11 PATENT ANALYSIS
  • 5.11.1 LIST OF MAJOR PATENTS
• 5.12 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.14 INVESTMENT & FUNDING SCENARIO
• 5.15 IMPACT OF ARTIFICIAL INTELLIGENCE (AI) ON SURGICAL SPONGES MARKET

6 SURGICAL SPONGES MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 COTTON GAUZE SPONGES
  • 6.2.1 SUPERIOR PROPERTIES OF COTTON GAUZE TO PROPEL GROWTH
• 6.3 X-RAY-DETECTABLE SPONGES
  • 6.3.1 ENHANCED PATIENT SAFETY TO BOOST DEMAND
• 6.4 NONWOVEN SPONGES
  • 6.4.1 LINT-FREE NATURE OF NONWOVEN SPONGES TO DRIVE GROWTH
• 6.5 LAPAROTOMY SPONGES
  • 6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET
• 6.6 OTHER SURGICAL SPONGES

7 SURGICAL SPONGES MARKET, BY MATERIAL

• 7.1 INTRODUCTION
• 7.2 COTTON
  • 7.2.1 HIGH ABSORBENCY AND WIDE AVAILABILITY TO BOOST MARKET
• 7.3 RAYON
  • 7.3.1 EXCEPTIONAL ABSORBENCY AND SOFTNESS TO PROPEL GROWTH
• 7.4 PVA
  • 7.4.1 BIOCOMPATIBILITY OF PVA SPONGES TO DRIVE ADOPTION
• 7.5 OTHER MATERIALS

8 SURGICAL SPONGES MARKET, BY SHAPE

• 8.1 INTRODUCTION
• 8.2 SQUARE & RECTANGLE
  • 8.2.1 ADAPTABILITY AND WIDE USE TO BOOST MARKET GROWTH
• 8.3 ROUND & CYLINDRICAL
  • 8.3.1 PRECISION AND EASE OF MAINTAINING PATIENT SAFETY TO DRIVE MARKET
• 8.4 OTHER SHAPES

9 SURGICAL SPONGES MARKET, BY STERILITY

• 9.1 INTRODUCTION
• 9.2 STERILE SURGICAL SPONGES
  • 9.2.1 EMPHASIS ON INFECTION CONTROL AND PREVENTION IN HEALTHCARE SETTINGS TO PROMOTE MARKET GROWTH
• 9.3 NON-STERILE SURGICAL SPONGES
  • 9.3.1 WIDE USE IN CLEANING WOUNDS AND DRESSING MINOR INJURIES TO PROPEL GROWTH

10 SURGICAL SPONGES MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 GENERAL SURGERY
  • 10.2.1 RISING NUMBER OF HERNIA REPAIR PROCEDURES TO DRIVE MARKET
• 10.3 NEUROSURGERY
  • 10.3.1 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH
• 10.4 LAPAROTOMY
  • 10.4.1 RISING NUMBER OF LAPAROTOMY PROCEDURES WORLDWIDE TO DRIVE MARKET
• 10.5 DENTAL SURGERY
  • 10.5.1 RISING PREVALENCE OF ORAL DISEASES AND GROWING AWARENESS OF DENTAL CARE TO DRIVE GROWTH
• 10.6 ENT SURGERY
  • 10.6.1 INCREASING DISPOSABLE INCOME AND AFFORDABILITY TO BOOST GROWTH
• 10.7 OTHER APPLICATIONS

11 SURGICAL SPONGES MARKET, BY END USER

• 11.1 INTRODUCTION
• 11.2 HOSPITALS & AMBULATORY SURGERY CENTERS
  • 11.2.1 RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS IN HEALTHCARE TO PROMOTE MARKET GROWTH
• 11.3 SPECIALTY CLINICS
  • 11.3.1 GROWING NUMBER OF SURGERIES TO DRIVE MARKET

12 SURGICAL SPONGES MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 12.2.2 US
    • 12.2.2.1 Strong healthcare infrastructure to support market growth
  • 12.2.3 CANADA
    • 12.2.3.1 Growing geriatric population and increasing volume of surgeries to drive demand
• 12.3 EUROPE
  • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPEAN UNION
  • 12.3.2 GERMANY
    • 12.3.2.1 Increasing healthcare expenditure and rising per capita disposable income to propel market
  • 12.3.3 UK
    • 12.3.3.1 Growing volume of cardiovascular surgeries to drive market
  • 12.3.4 FRANCE
    • 12.3.4.1 Presence of robust healthcare systems to augment market
  • 12.3.5 ITALY
    • 12.3.5.1 Rising geriatric population and increasing number of chronic diseases to support market
  • 12.3.6 SPAIN
    • 12.3.6.1 Growing demand for effective surgical outcomes to create major growth opportunities
  • 12.3.7 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 MACROECONOMIC OUTLOOK FOR EAST ASIA & PACIFIC
  • 12.4.2 CHINA
    • 12.4.2.1 Rising number of hospitals and greater public access to modern healthcare to drive market
  • 12.4.3 JAPAN
    • 12.4.3.1 Rising prevalence of chronic diseases and robust healthcare system to support market
  • 12.4.4 INDIA
    • 12.4.4.1 Large patient population and developing healthcare sector to drive market
  • 12.4.5 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA & CARIBBEAN
  • 12.5.2 BRAZIL
    • 12.5.2.1 Increasing cases of accidents and traumas to fuel market
  • 12.5.3 MEXICO
    • 12.5.3.1 Low-cost surgeries and enhanced healthcare infrastructure to aid market
  • 12.5.4 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET
  • 12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & NORTH AFRICA
• 12.7 GCC COUNTRIES
  • 12.7.1 ADVANCEMENTS AND INCREASED GOVERNMENT INVESTMENTS IN HEALTHCARE SECTOR TO PROPEL MARKET
  • 12.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 13.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN SURGICAL SPONGES MARKET
• 13.3 REVENUE ANALYSIS
• 13.4 MARKET SHARE ANALYSIS
• 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Type footprint
    • 13.5.5.3 Material footprint
    • 13.5.5.4 Shape footprint
    • 13.5.5.5 Sterility footprint
    • 13.5.5.6 Application footprint
    • 13.5.5.7 End-user footprint
    • 13.5.5.8 Region footprint
• 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 STARTING BLOCKS
  • 13.6.3 RESPONSIVE COMPANIES
  • 13.6.4 DYNAMIC COMPANIES
  • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 13.7 VALUATION & FINANCIAL METRICS
• 13.8 BRAND/PRODUCT COMPARISON
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 DEALS
  • 13.9.2 EXPANSIONS
  • 13.9.3 OTHER DEVELOPMENTS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 JOHNSON & JOHNSON SERVICES, INC.
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products offered
    • 14.1.1.3 MnM view
      • 14.1.1.3.1 Right to win
      • 14.1.1.3.2 Strategic choices
      • 14.1.1.3.3 Weaknesses & competitive threats
  • 14.1.2 MCKESSON CORPORATION
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products offered
    • 14.1.2.3 MnM view
      • 14.1.2.3.1 Key strengths
      • 14.1.2.3.2 Strategic choices
      • 14.1.2.3.3 Weaknesses and competitive threats
  • 14.1.3 CARDINAL HEALTH
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products offered
    • 14.1.3.3 MnM view
      • 14.1.3.3.1 Key strengths
      • 14.1.3.3.2 Strategic choices
      • 14.1.3.3.3 Weaknesses and competitive threats
  • 14.1.4 3M
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Other developments
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Key strengths
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses and competitive threats
  • 14.1.5 INTEGRA LIFESCIENCES CORPORATION
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Deals
  • 14.1.6 MEDICOM
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products offered
  • 14.1.7 MEDLINE INDUSTRIES, LP.
    • 14.1.7.1 Business overview
    • 14.1.7.2 Product offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Expansions
  • 14.1.8 DEROYAL INDUSTRIES, INC.
    • 14.1.8.1 Business overview
    • 14.1.8.2 Product offered
  • 14.1.9 DUKAL LLC
    • 14.1.9.1 Business overview
    • 14.1.9.2 Product offered
  • 14.1.10 DYNAREX CORPORATION
    • 14.1.10.1 Business overview
    • 14.1.10.2 Product offered
• 14.2 OTHER PLAYERS
  • 14.2.1 OWENS & MINOR
  • 14.2.2 ADVACARE PHARMA
  • 14.2.3 FIRST AID BANDAGE COMPANY
  • 14.2.4 MOLNLYCKE HEALTH CARE AB
  • 14.2.5 ALLCARE
  • 14.2.6 NARANG MEDICAL LIMITED
  • 14.2.7 AEGIS LIFESCIENCES
  • 14.2.8 SUNDARAM SURGICAL
  • 14.2.9 ASPEN SURGICAL PRODUCTS
  • 14.2.10 OMNI INTERNATIONAL CORP

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS